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Background: Population based studies are important for prevalence, incidence and association studies, but their
external validity might be threatened by decreasing participation rates. The 50 807 participants in the third survey
of the HUNT Study (HUNT3, 2006-08), represented 54% of the invited, necessitating a nonparticipation study.
Methods: Questionnaire data from HUNT3 were compared with data collected from several sources: a short
questionnaire to nonparticipants, anonymous data on specific diagnoses and prescribed medication extracted from
randomly selected general practices, registry data from Statistics Norway on socioeconomic factors and mortality,
and from the Norwegian Prescription Database on drug consumption.
Results: Participation rates for HUNT3 depended on age, sex and type of symptoms and diseases, but only small
changes were found in the overall prevalence estimates when including data from 6922 nonparticipants. Among
nonparticipants, the prevalences of cardiovascular diseases, diabetes mellitus and psychiatric disorders were higher
both in nonparticipant data and data extracted from general practice, compared to that reported by participants,
whilst the opposite pattern was found, at least among persons younger than 80 years, for urine incontinence,
musculoskeletal pain and headache. Registry data showed that the nonparticipants had lower socioeconomic status
and a higher mortality than participants.
Conclusion: Nonparticipants had lower socioeconomic status, higher mortality and showed higher prevalences of
several chronic diseases, whilst opposite patterns were found for common problems like musculoskeletal pain, urine
incontinence and headache. The impact on associations should be analyzed for each diagnosis, and data making
such analyses possible are provided in the present paper.
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Population based studies are pivotal for knowledge on
health related behavior, prevalence and incidence of
symptoms, diseases and death, as well as for assessing
potential causal associations in the population. The val-
idity of incidence and prevalence studies rely on the
sample of study participants being representative of the
actual population, and if participation is influenced by
exposures and diseases under study, this may also bias
association studies.* Correspondence: arnulf.langhammer@ntnu.no
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distribution, and reproduction in any mediumParticipation rates in population-based studies have
declined during the last three decades [1], and this is
the case also in most Norwegian epidemiological
studies such as the Nord-Trøndelag Health Study
(HUNT) [2-4], the Hordaland Health Study [5] and The
Oslo Health Study [6].
The adult population of the Nord-Trøndelag County,
Norway, has been invited to three main surveys, HUNT1
(1984-86), HUNT2 (1995-97) and HUNT3 (2006-08).
Data from this study are extensively used in national and
international research, and have per 2012 been the basis
of about 600 peer reviewed papers and about 70 doctoral
theses. Studies after HUNT1 and 2 indicated only minor
potential nonparticipation bias, but these were restrictedentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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ticipation rate from 88% in HUNT1, 71% in HUNT2 to
54% in HUNT3, an updated thorough nonparticipation
study was warranted.
The present study had three main objectives:
a) To study potential participation bias for common
symptoms, diseases and socioeconomic status in
HUNT3
b)To study mortality by participation status in HUNT
c) To provide dcata as basis for future sensitivity
analyses in disease specific studies
Methods
The HUNT study
2In each survey of the adult part of the HUNT Study
every citizen of Nord-Trøndelag County aged 20 years
and older was invited. The population is homogenous,
lives in mainly rural areas with five smaller towns, and
has a level of education and income a little beneath the
national average. However, mortality and health status is
fairly representative of Norway [3,8]. The design and
methods applied in the three surveys were by and large
unchanged, but each time the scientific program was
extended [4].
Data sources
1) The HUNT3 questionnaires. A questionnaire (Q1)
was mailed together with the personal invitation, to be
completed and delivered when attending the examin-
ation stations. At the examination, questionnaire 2 (Q2)
and 3 (Q3) were handed out, these should be completed
at home and posted to HUNT Research Centre in a pre-
paid envelope. Q1 and Q2 included questions about
quality of life, life style, symptoms, prior or current dis-
eases and health care utilization, while Q3 (9 versions)
was aimed at subgroups with specific diseases and use of
health care. Some 99.7% of those delivering Q1 did also
participate in the standard examination programme.
Nonparticipants received one reminder.
2) Questionnaire for nonparticipants (QNP). About
nine months after completion of the HUNT3 survey, a
two page questionnaire (QNP) and a prepaid envelope
for return were mailed to all nonparticipants in HUNT3
if they were still alive and residing in the county. The
questionnaire included identical core questions on
symptoms, diseases and life style as in Q1 and Q2, as
well as questions on reasons for nonparticipation in
HUNT3.
3) General practitioner (GP) data. In 2007 a total of
102 GPs were practising in Nord-Trøndelag County, out
of which 2/3 used the electronic patient journal Profdoc,
Winmed version 2.2. Among Winmed users, eight prac-
tices with 30 GPs were randomly selected for dataextraction of selected anonymous data from the patient
records during January-May 2011. From patients on the
doctors list aged 20-100 by the 1st of January 2011 these
data were extracted: Number of consultations during the
last year, diagnoses according to The International Clas-
sification of Primary Care codes (ICPC2), prescription of
selected drugs in the last year and asthma medication
during the last five years according to Anatomical Thera-
peutic Chemical Classification System (ATC).
4) Register data. Data on dispensed drugs during 2008
for inhabitants of the Nord-Trøndelag County was
retrieved from the Norwegian Prescription Database
(NorPD) [9]. The invitation file for HUNT 3 including
variables for age, sex, and participation status was sent
to Statistics Norway [10] for merging with data on mor-
tality, education, income (quintiles), social security and
social assistance (sick leave, rehabilitation, time-limited
or permanent disability pension), marital status and type
of municipality. Data comparisons between participants
and nonparticipants were performed in an anonymous
file. Education, income and marital status were chosen
as status of 1st January 2007, whilst the other variables
reflected the study period 2006-2008.
Statistical analyses
In all study parts the numbers of invited and participat-
ing individuals are reported, providing several participa-
tion rates as recommended [1]. The participation rates
derived from questionnaire data refer to Q1 and QNP.
Questions derived from Q2 are marked in the tables.
When comparing data from Q1 or Q2, QNP and the
extracted GP data, results are stratified by age groups
(20-39, 40-59, 60-79 and 80+). In the registry and mor-
tality studies we stratified age into three groups, 20-39,
40-64 and 65+, the latter group mainly being retired. For
comparison with extracted GP data, only HUNT3 data
derived from the corresponding eight municipalities
were used. Data on dispensed drugs from NorPD refers
to the entire county for the year 2008.
The statistical software SPSS version 17 was used for
testing differences between proportions with chi square
tests, whilst Stata version 11 for Windows was used for
estimation of relative risks with binomial regression
(generalized linear model with a log link function as-
suming a negative binomial distribution), for the estima-
tion of hazard ratios of death in Cox proportional
regression analyses, and for age adjusted Kaplan Meier
plots of survival. In these analyses follow-up time was
from August 1986 for HUNT1, August 1997 for HUNT2
and August 2008 for HUNT3 to the date of death or
until 4th of July 2010, whichever came first. Start of
follow-up was set to two months after the HUNT sur-
veys to avoid the impact of terminally ill subjects during
the surveys.
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When comparing Q1/Q2 and QNP (Table 1) answers to
the question “How is your health at present?” were
dichotomized into poor/very poor and good/very good.
The mean score of CONOR Mental health Index (MHI)
[11], including 7 items each with score 1-4 on mental
distress was calculated, and proportions of those scoring
above 2.15 are reported. Comparing answers in Q1/Q2
and GP data, combined diagnosis according to ICPC-2
or ATC-codes for medications are reported (Table 2).
Anxiety and depressive symptoms were ascertained
using the Hospital Anxiety and Depression Score
(HADS) [12] in HUNT3, and categorized as dichotom-
ous variables using a cut-off score of ≥ 8 on the HADS-
anxiety or HADS-depression, respectively [13].
Ethics
All participants at HUNT3 were informed and gave writ-
ten consents to participation in the main and follow-up
studies. The Norwegian Data Inspectorate has licensed
HUNT Research Centre to store and link data collected
in all HUNT surveys. All HUNT surveys, and the
present nonparticipant study, are approved by The Re-
gional Committee for Medical and Health Research
Ethics.
Results
In HUNT3, 46 567 men and 47 293 women aged
20 years or more were invited and 23 049 (49.5%) men
and 27 758 (58.7%) women answered at least one ques-
tion in Q1 (Table 1). The lowest participation rates were
found in age groups 20-39 and 80+. The questions were
completed by 95-99% of the participants with minor dif-
ferences between diseases, symptoms and life style fac-
tors. For life style questions (use of alcohol, snuff,
smoking and exercise) the proportion of missing
increased by age group from about 2% in the youngest
to 12% among those aged 80 years or more. The first
question in Q1 was answered by 97.0% whilst the last
one was answered by 98.6%. The response rate to ques-
tions in Q2 varied from 73% to 80% out of all who
answered Q1.
Comparing HUNT3 questionnaires with nonparticipation
questionnaire data
In all 3241 women and 3677 men returned QNP and
had answered at least one question. They represent 6.9%
and 7.9% of women and men invited to HUNT3
(Table 1). The percentages were similar after exclusion
of 498 women and 531 men having died or emigrated
between the invitation to HUNT Q1 and QNP. For
questions on life style factors missing increased from 1%
to 4% by increasing age group, for cardiovascular dis-
eases there were 50% missing data in the youngest agegroups. For other diseases and symptoms the proportion
of missing increased from 2% in the youngest group to
10-14% in the oldest. Among participants at HUNT2
who were invited to HUNT3, some 70.7% answered Q1
(HUNT3) and 6.4% QNP compared to 29.3% and 8.5%
among nonparticipants at HUNT2.
Self-reported body heights and weights were slightly
higher and lower, respectively, in QNP compared to
measurements of participants at the examination, giving
BMI based on measurement 0.6 and 1.1 kg/m2 higher in
men and women. Except for age group 40-59 years,
similar proportions in the two groups had visited GP
during the last 12 months, but independent of age and
sex, larger proportions in the QNP group had been hos-
pitalized compared to the Q1 group.
More participants of QNP compared to Q1 reported
poor/very poor health, mental distress and insomnia in
the evenings (Table 1). In women 40 years and older
chronic disease limiting daily functions was reported
more often in the QNP than Q1 group. No difference
between groups were found in men at similar age, but in
younger men the highest proportion of affirmative
answers to this question was found in the Q1 group.
The prevalence of self-reported symptoms varied be-
tween the questionnaires by symptom types. A lot of
heartburn was more often reported in Q1/Q2 than in
QNP in all age groups, and similar patterns were found
for symptoms like chronic musculoskeletal pain and
urine incontinence in the age group 20-60 years, but with
opposite pattern among the oldest (Table 1, Additional
file 1 Table S1, Additional file 2 Table S2). For respiratory
symptoms (cough, wheezing and breathlessness), head-
ache and migraine there were minor differences without
any consistent pattern by sex or age groups.
Compared to Q1, higher proportions in QNP reported
chronic diseases such as arterial hypertension (drug trea-
ted), myocardial infarction, angina pectoris, stroke, renal
disease, diabetes, fibromyalgia, arthrosis and that they
ever had sought help for mental problems in age groups
40-59 years and older. Regarding asthma and COPD
there were no substantial differences in women, but in
men COPD was reported more often in QNP compared
to Q1 in all age groups with 55% difference all over. For
hypo- and hyperthyroidism and cancer no between
groups difference was found.
Among men above age 39 years, daily smoking and
use of snuff were more prevalent in QNP compared to
Q1, whilst this was not found among women. In both
sexes more never-smokers participated in Q1 compared
to QNP. Intake of alcohol 2-3 times a week or more,
was reported more often in Q1 than QNP in women,
whilst no difference was found among men. In Q1 exer-
cising 2-3 times a week or more, was reported more
often than in QNP in both sexes.
Table 1 Comparisons of anthropometrics (means) and percentages reporting symptoms and diseases between
responders to the main questionnaires (Q1 or Q2) and the nonparticipation questionnaire (QNP)
Women Men
Q1 QNP p Q1+ QNP Q1 QNP p Q1+ QNP
Number invited ¤ 47 293 19 004 46 567 23020
Number participated 27 758 3241 30 999 23 049 3677 26 726
Percent of invited to HUNT3 58.7 6.9 65.6 49.5 7.9 57.4
Height (cm) # 164.6 166.3 <0.01 164.7 177.8 179.6 <0.01 178.0
Weight (kg) # 72.9 71.5 <0.01 72.8 86.9 86.7 0.51 86.8
BMI (kg/m2) # 26.9 25.8 <0.01 26.8 27.5 26.9 <0.01 27.4
General practitioner last 12 months 83.9 84.6 0.30 83.9 74.5 74.2 0.74 74.4
Hospitalized last year 12.4 20.1 <0.01 13.1 10.9 14.0 <0.01 11.3
Current health poor or very poor 28.4 29.6 0.20 28.5 23.4 24.1 0.36 23.5
Mental distress £ 7.9 12.1 <0.01 8.3 6.3 9.4 <0.01 6.8
Insomnia many evenings a week 14.8 16.2 0.03 15.0 7.5 10.2 <0.01 8.0
Wake up early in the morning many days a week 12.2 11.9 0.66 12.1 9.6 8.2 <0.01 9.4
Chronic disease limiting daily functions 33.9 33.9 1.00 33.9 32.4 27.9 <0.01 31.8
Daily cough in periods (Q2) 19.1 20.7 0.04 19.3 22.6 20.3 <0.01 22.2
Attacks of wheezing or breathlessness 12.4 11.3 0.09 12.3 12.3 12.2 0.95 12.3
Allergic rhinitis (Q2) 23.1 25.3 <0.01 23.4 18.7 21.8 <0.01 19.2
Heartburn (a lot) (Q2) 7.1 4.4 <0.01 6.7 7.2 4.8 <0.01 6.8
Headache (Q2) 42.1 44.7 <0.01 42.4 27.8 27.3 0.51 27.7
Migraine (Q2) 10.9 11.8 0.09 11.0 5.0 5.3 0.45 5.0
Musculoskeletal pain of more than 3 months 54.6 41.9 <0.01 53.0 45.1 31.6 <0.01 42.9
Urine incontinence (Q2) 26.8 20.6 <0.01 26.1 8.7 5.2 <0.01 8.2
Medication for arterial hypertension 20.5 24.9 <0.01 20.8 21.4 23.8 <0.01 21.7
Myocardial infarction 1.6 3.1 <0.01 1.7 5.2 6.9 <0.01 5.4
Angina pectoris 2.5 3.2 0.04 2.7 4.8 5.9 0.01 5.0
Cerebral insult 2.2 3.5 <0.01 2.3 3.0 3.7 0.03 3.1
Renal disease 2.6 3.9 <0.01 2.7 2.5 3.8 <0.01 2.7
Asthma 10.4 10.9 0.39 10.4 9.4 10.5 0.04 9.5
COPD or chronic bronchitis 3.3 3.9 0.14 3.3 3.4 5.3 <0.01 3.7
Diabetes 3.8 5.7 <0.01 4.0 4.9 6.6 <0.01 5.2
Cancer 5.6 5.6 0.94 5.6 4.9 4.6 0.55 4.8
Osteoporosis 5.3 5.9 0.20 5.3 0.7 1.1 0.03 0.8
Fibromyalgia 6.3 7.4 0.03 6.4 0.8 1.3 <0.01 0.9
Arthrosis 18.8 21.4 <0.01 19.0 10.3 11.9 0.01 10.5
Sought help for mental problem 16.9 20.6 <0.01 17.7 9.9 11.7 <0.01 10.1
Hyperthyreosis 2.8 3.0 0.56 2.8 0.9 0.5 0.05 0.8
Hypothyreosis 9.3 10.0 0.30 9.4 2.3 1.8 0.06 2.2
Never-smoker } 47.3 44.4 <0.01 47.0 44.3 41.1 <0.01 43.8
Ex-smoker 27.4 26.1 0.13 27.3 35.2 31.1 <0.01 34.6
Occasional smoker 9.4 9.3 0.92 9.4 9.7 9.2 0.38 9.6
Daily smoker 20.6 20.2 0.59 20.6 16.9 18.7 <0.01 17.1
Daily use of snuff 1.2 1.9 <0.01 1.3 13.8 17.0 <0.01 14.3
Langhammer et al. BMC Medical Research Methodology 2012, 12:143 Page 4 of 14
http://www.biomedcentral.com/1471-2288/12/143
Table 1 Comparisons of anthropometrics (means) and percentages reporting symptoms and diseases between
responders to the main questionnaires (Q1 or Q2) and the nonparticipation questionnaire (QNP) (Continued)
Alcohol > 2-3 times a week 12.0 9.5 <0.01 11.3 18.8 17.8 0.16 18.6
Exercise > 2-3 times a week 20.5 14.0 <0.01 19.8 17.3 13.9 <0.01 16.9
Questions from Q2 are marked.
¤ Invited to QNP, persons having died or emigrated between HUNT3 and QNP are excluded.
# Height and weight measured at the screening stations, self-reported in QNP.
} Questions on tobacco smoking; included in n if answered at least one of the smoking related questions.
£ CONOR Mental Health Index (CONOR MHI) consists of 7 questions on mental distress with score 1-4. Mean score calculated and cut-off for dichotomization
was≥ 2.15.
Corresponding data stratified by age and sex are given in Table S1 and Table S2.
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rate increased to 65.6% and 57.4% out of those invited to
HUNT3 for women and men, respectively. For most symp-
toms and diseases, the prevalence estimates did not change
substantially by combining these data sources (Table 1).
Comparing HUNT3 questionnaire with general practice
data
In all, data on 13 821 women and 14 454 men were
extracted from GP records. The age and sex distribution
of the GP population was representative of the county
population (Table 2).
A lot of heartburn was reported less often in HUNT
than diagnosed heartburn or esophagitis by GPs (Table 3),
and higher prevalence was found for prescriptions of medi-
cations mainly used at these indications (data not shown).
The proportion of patients with diagnoses of cardiovascu-
lar diseases (angina, myocardial infarction and stroke) in
GP records was higher than the prevalence of correspond-
ing self-reported diseases. There was, however, close agree-
ment between the two data sets regarding use of
antihypertensive treatment. Interestingly, data from NorPD
showed more prevalent use of such drugs, but these areTable 2 Number of persons, mean age and percentages havin





HUNT3: Answered Q1 2785
GPs: Listed patients aged≥ 20 years 4364
Mean age
HUNT3: Mean age within age groups among all invited 29.7
HUNT3: Mean age within age groups among all Q1 part. 31.4
GPs: Mean age within age groups in the patient population 29.0
Consultations
HUNT3 Reported GP visit last year 65.0
GP: Registered > 1 visit to GP last year 58.9
Data restricted to the municipalities including eight randomly selected general prac
municipalities.also indicated for other diseases than arterial hypertension.
In HUNT3 there were questions on each of the diagnoses
of spondylarthritis and rheumatoid arthritis, whilst these
diseases have a common diagnostic code in ICPC-2. Com-
bining these diagnoses showed a fair agreement between
the two sources, and similar consistency was also found for
arthrosis and osteoporosis in women, but GP-data indi-
cated 20% higher prevalence of arthrosis among men than
reported by HUNT participants.
A high proportion of participants in HUNT3 reported
bothersome headache, but the prevalence of the diagno-
sis of headache in GP records was close to one third of
this. However, for the more specific diagnosis of mi-
graine, the prevalence in general practice was only
slightly lower than self-reported prevalence in HUNT3.
The frequency of migraine attacks varies from a few
attacks per decade to many attacks a week; in line with
this NorPD data showed that only 0.8% of men and 3.4%
of women had migraine medication dispensed during
one year (2008).
Data in HUNT3 were not eligible for direct compari-
son of prevalence of anxiety and depression with the GP
data. However, the prevalence of diagnosed anxiety byg consulted general practitioner in the last 12 months
those being registered at the general practices
omen age groups Men age groups
40-59 60-79 80 + 20-39 40-59 60-79 80 +
10 577 6274 1400 8528 10 093 6537 2299
5657 4057 552 3898 6510 4631 782
5346 3926 818 3848 5209 3559 1205
49.4 67.7 84.4 29.7 49.4 68.1 85.3
50.5 68.0 83.8 31.2 50.3 68.2 84.2
49.4 67.6 84.8 29.4 49.2 68.0 85.7
71.7 86.3 93.7 82.7 82.3 89.7 92.3
71.3 86.5 92.7 78.9 84.5 90.2 89.2
tices (GPs). The 28 872 HUNT3 participants represented 57% of invited in these
Table 3 Prevalence data (%) based on HUNT3 questionnaires (Q1 or Q2) and general practitioner diagnoses (GPD)
Women age groups Men age groups
20-39 40-59 60-79 80 + 20-39 40-59 60-79 80 +
Heart burn
Q2: A lot of heart burn 6.1 7.9 6.3 6.2 4.9 6.3 8.6 7.9
GPD: Heart burn or reflux (D03/D84) 3.9 8.2 10.0 11.0 2.5 7.6 12.1 12.0
Cardiovascular diseases
Q1: Angina pectoris 0.3 1.5 9.6 21.4 0.2 0.7 4.4 15.5
GPD: Angina pectoris (K74) 0.1 2.2 13.9 26.4 0 0.8 6.8 21.1
Q1: Myocardial infarction 0.1 2.3 10.1 21.2 0.0 0.5 3.0 8.6
GPD: Myocardial infarction (K75or K76) 1.0 3.3 12.9 18.8 0.5 1.3 4.7 10.4
Q1: Cerebral insult 0.6 1.5 5.4 11.6 0.3 1.1 3.9 8.6
GPD: Cerebral insult (K90 + 91) 0.4 2.2 7.3 17.0 0.4 1.4 5.7 14.2
Q1: Arterial hypertension 1.2 14.7 38.1 44.1 2.1 12.7 36.9 49.8
GPD: Arterial hypertension (K86 or K87) 2.7 14.7 37.4 42.2 2.2 12.9 37.1 49.4
NorPD: Drugs arterial hyper-tension (C02-03, 07–09) 1.7 16.0 51.5 70.3 2.2 15.7 49.5 67.7
Inflammatory and musculoskeletal diseases
Q1: Spondylarthritis or
rheumatoid arthritis 1.5 4.1 5.3 6.0 1.9 4.7 7.2 8.8
GPD: Spondylarthritis or rheumatoid arthritis (L88) 1.5 3.4 4.5 5.6 1.5 4.7 7.9 8.7
Q1: Arthrosis 0.8 6.1 17.2 23.3 1.0 12.8 34.2 45.5
GPD: Arthrosis hip or knee (L 89 + 90+ 91) 1.7 7.5 21.5 29.8 1.7 10.2 33.6 43.4
Q1: Osteoporosis 0.1 0.3 1.2 3.1 0.3 1.9 11.1 20.6
GPD: Osteoporosis L95 0.2 0.6 1.5 2.9 0.2 1.4 10.8 22.7
Neurological diseases
Q1: Headache 37.0 34.3 18.7 10.7 56.9 47.7 26.8 16.6
GPD: Headache (N01) 10.8 9.9 7.9 6.1 18.6 16.5 12.6 11.0
Q1: Migraine 3.1 4.5 2.7 3.4 10.4 11.2 5.1 5.0
GPD: Migraine (N89) 3.8 4.4 2.6 1.5 9.5 11.6 7.1 2.4
NorPD: Use of migraine drugs (N02) 1.0 1.0 0.5 0.2 3.5 4.9 2.0 0.3
Q1: Epilepsy 1.5 1.2 1.2 1.9 1.3 1.4 0.7 1.4
GPD: Epilepsy (N88) 1.8 1.7 1.8 1.5 1.5 1.7 1.5 1.2
Mental diseases and insomnia
Q2: HADS anxiety score > 8# 11.9 11.7 7.2 8.2 18.4 17.4 15.6 13.2
GPD: Anxiety or feeling of anxiety (P 01 + 74 +79) 6.7 8.5 8.5 8.6 9.7 14.1 14.0 15.4
Q2: HADS depression score > 8# 6.4 9.4 11.7 18.8 6.2 8.3 9.8 16.3
GPD: Depression or feeling of depression (P 03 + 76) 11.0 18.1 16.0 11.1 19.6 31.3 28.0 21.7
Q2: Insomnia many evenings or mornings a week 11.6 13.8 16.2 15.4 13.1 21.3 25.8 25.3
GPD: Sleeping disorder (P06) 6.3 8.6 18.8 24.0 6.3 13.3 21.7 32.4
Respiratory diseases
Q1: COPD or chronic bronch 1.0 2.0 5.6 5.4 1.5 2.7 4.6 4.2
GPD: COPD or chronic bronchitis (R95) 0.1 1.9 7.9 13.2 0.2 1.8 7.2 7.0
Q1: Asthma 10.5 9.3 9.4 7.2 12.4 9.4 10.4 8.6
GPD: Asthma (R96) 10.6 7.0 9.2 10.0 10.4 9.7 11.9 9.9
Q1: Use of asthma or copd drugs in the last 5 years 8.1 7.5 11.3 9.6 10.4 9.6 12.5 9.7
GP prescription asthma drugs in the last 5 year (R03) 7.4 8.7 15.1 17.4 9.8 11.4 17.3 12.6
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Table 3 Prevalence data (%) based on HUNT3 questionnaires (Q1 or Q2) and general practitioner diagnoses (GPD)
(Continued)
NorPD: Use of asthma drugs in 2008 (R03) 4.6 5.6 11.6 14.2 5.7 7.7 13.0 9.1
Skin diseases
Q1: Psoriasis 4.1 6.8 7.0 3.8 3.3 6.2 6.6 4.1
GPD: Psoriasis (S91) 2.0 4.6 5.5 4.6 2.7 4.5 5.8 2.8
Endocrine disorders
Q1: Hyperthyreosis 0.3 0.7 1.3 2.5 1.4 2.6 3.4 3.2
GPD: Hyperthyreosis (T85) 0.2 0.5 0.7 0.7 0.6 1.9 2.0 2.0
Q1: Hypothyreosis 0.6 2.1 2.9 5.3 4.1 8.0 12.3 12.1
GPD: Hypothyreosis (T86) 1.4 1.9 4.2 6.7 3.2 7.8 12.7 13.8
GP prescription thyroid hormone (H03AA01) 0.5 1.5 3.3 5.1 2.2 7.0 12.1 12.5
NorPD: Use of thyroid hormone (H03AA01) 0.5 2.0 3.7 5.9 2.6 7.9 14.2 13.4
Q1: Diabetes mellitus 0.8 3.4 9.2 9.2 0.8 2.4 6.9 9.7
GPD: Diabetes mellitus (T89 + 90) 1.2 4.8 13.7 16.3 1.4 3.6 10.4 13.0
GP prescription antidiabetic drug (A10A or A10B) 0.8 4.0 10.9 10.9 1.2 2.8 7.9 8.8
NorPD: Antidiabetic drug (A10A or A10B) 1.1 4.1 11.1 11.7 1.5 2.6 8.4 9.2
Urinary tract
Q2: Urinary incontinence 4.7 7.6 10.4 13.1 22.2 27.5 27.4 32.8
GPD: Urinary incontinence (U04) 1.0 0.5 3.0 8.7 2.2 6.8 10.5 22.0
HUNT data are restricted to the municipalities being represented by eight randomly selected general practices, and include 28 872 HUNT3 participants (57% of
invited in these municipalities). Data from Norwegian Prescription Registry (NorPD) include the entire county for the year 2008.
# Hospital Anxiety and Depression Scale (HADS) 14 items, cut-off 8 indicate minor, moderate and severe disease (REF).
In parenthesis: For diagnosis – codes according to the International Classification of Primary Care (ICPC2), for medication codes according to The Anatomical
Therapeutic Chemical Classification System (ATC).
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http://www.biomedcentral.com/1471-2288/12/143GP was slightly lower compared to the prevalence hav-
ing a HADS-anxiety symptom score of 8 or higher. Cor-
responding comparison between diagnosed depression
and HADS depression symptom score 8 or higher
showed much lower estimated prevalence of depression
amongst HUNT3 participants. Among the oldest age
groups sleeping disorders were more often diagnosed in
GP records than reported by HUNT participants, whilst
the opposite pattern was found in younger age groups.
Higher prevalence of COPD diagnosis was found in GP
data compared to self-reported data in HUNT3 among
those aged 60 years and older, whilst there were relatively
small differences regarding asthma. Reported use of asthma
or COPD medication in HUNT3 was somewhat lower com-
pared to data from GP, especially in the older age groups.
For hypothyreosis and corresponding prescribed and
dispensed thyroid hormones there were rather consistent
data, whilst hyperthyreosis was less often diagnosed in GP
records. The diagnosis of diabetes was more prevalent in the
GP population than the self-reported data from HUNT3
indicated. Data on both prescribed and dispensed insulin
and oral medication for diabetes suggested an underesti-
mation of prevalence data from HUNT3, as a substantial
number with diabetes also are treated with life style only. Self-
reported urine incontinence was more prevalent in HUNT3
compared to the proportion having been diagnosed by GPs.Comparing data from GP records, questionnaire Q1 and
questionnaire QNP
Comparing over all prevalence either of diagnoses regis-
tered in general practices and self-reported data from Q1
and Q2 show minor differences for asthma (Figure 1). For
persons 60 years and older, there were similar patterns for
apoplexia, myocardial infarction, COPD and diabetes, with
lowest prevalence in Q1, intermediate in GP-data and high-
est among QNP-participants. Assuming that the preva-
lences of chronic diseases found in the QNP group were
representative for the entire nonparticipation group 60 years
and older, the combined prevalences for nonparticipants
and Q1 participants compared to estimates from GP
records, would be 6.6 versus 8.4% for apoplexia, 9.8 versus
10.0% for myocardial infarction, 9.9 versus 10.3% for
asthma, 5.7 versus 8.0% for COPD and 10.3 versus 12.6%
for diabetes.
Among persons younger than 60 years, symptomatic
diseases like COPD, migraine and insomnia were
more prevalent in Q1 and QNP data than diagnosed in
general practice.
Self-reported reasons for nonparticipation
About 10% reported that they had not received invitation
to HUNT3 (Table 4). Otherwise the most important rea-
son for nonparticipation was lack of time or inconvenient












General practice          20-59 yrs
Questionnaire 1           20-59 yrs
Questionnaire nonpart. 20-59 yrs
General practice          60 yrs +
Questionnaire 1           60 yrs +










Figure 1 Prevalence of diseases (%) based on GP records, HUNT questionnaire 1 (Q1) and QNP by age group.
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http://www.biomedcentral.com/1471-2288/12/143session, this was reported by 50.7% in women and 56.6% in
men. Among the two oldest age groups, 4.0 % of women
and 6.4% of men reported they would have no benefit of
such examinations, while 11.7% of women and 7.7% of
men reported being too ill to participate.Comparing participants and non-participants in national
register data
The anonymous file included data on a) participants (27
758 women and 23 049 men), b) those having answered
QNP (3241 women and 3677 men) and c) those with no
participation (16 294 women and 19 841 men). The ana-
lyses include group “a” and “c”. Participation in HUNT
depended on sex, age, marital status, education and in-
come (Table 5). In those who received disability pension
the participation was lower, and even lower in those re-
ceiving social benefit compared to those not receiving
social security money. The participation was lower in
urban compared to rural municipalities.Table 4 Percentages reporting reasons for nonparticipation in
(M) having answered the nonparticipation questionnaire (QN
Reasons 20-39 years 40-59 years
W M W M
Did not receive the invitation 13.3 14.9 6.2 9.
Had not time /inconvenient session 60.7 64.5 54.9 61.
Don’t rely on such examinations 0.2 0.9 1.1 1.
No benefit of such examinations 0.3 1.7 1.6 1.
Too ill to attend the study 1.4 0.6 3.3 1.
Questions I did not wish to answer 2.1 1.2 3.9 3.
Other reason 25.1 17.5 30.0 22.
} p-values for chi-square tests comparing all men and women.Nonparticipants of HUNT surveys displayed a higher
mortality even many years after the surveys took place,
with increased mortality of 50%, 72% and 180% for nonpar-
ticipants compared to participants in HUNT1, HUNT2
and HUNT3, respectively (Table 6). Figure 2, 3 and 4 show
corresponding survival curves of participants and nonparti-
cipants of HUNT1 to 3 using age as the timeline and
Figure 5, 6 and 7 show the proportion having died,
adjusted for age (at 50 years), by time since the HUNT sur-
veys. Interestingly, there are similar patterns for risk of
death between participants and nonparticipants in surveys
with participation rate varying from 88 to 54%.
Discussion
Participation rates in HUNT3 depended on age, sex,
socioeconomic status and type of symptoms and dis-
eases. Among nonparticipants, the prevalence of com-
mon chronic diseases was higher compared to that
reported by participants. This included cardiovascular
diseases and diabetes mellitus, a pattern confirmed bythe HUNT study among 3241 women (W) and 3677 men
P)
60-79 years 80+ years All age groups
W M W M W M p}
3 8.5 9.1 8.0 10.7 9.5 11.1 0.02
9 34.8 40.2 14.3 20.8 50.7 56.6 <0.01
6 1.7 2.2 0.4 2.0 0.8 1.5 <0.01
8 3.1 4.8 6.3 8.1 1.7 2.6 <0.01
2 7.2 5.5 23.7 19.5 4.7 2.6 <0.01
5 6.8 7.0 3.6 4.0 3.7 3.5 0.61
1 32.1 27.2 24.6 18.8 28.1 21.5 <0.01
Table 5 Prevalence ratio and absolute difference (%) of participation (n =50 807) versus no participation*(n =36 135)
in the HUNT3 main questionnaire by different characteristics
Characteristic Prevalence ratio Difference in participation (%)
Crude Adjusted 95% CI Crude Adjusted 95% CI (%)
Sex (women/men) 1.17 1.23 1.20, 1.26 9.2 12.6 11.8,13.3
Age group
20-39 year 1 1 Reference 0 0 Reference
40-59 year 1.63 1.45 1.40, 1.50 25.2 19.1 18.2, 20.0
60-79 year 1.88 1.74 1.68, 1.81 34.7 29.9 29.0, 30.8
80 + yrs 1.12 1.23 1.16, 1.30 4.8 10.7 9.2, 12.1
Education
9 year or less 1 1 Reference 0 0 Reference
10-12 year 1.28 1.27 1.23, 1.30 13.6 13.6 12.8, 14.5
University 1.39 1.36 1.31, 1.41 19.0 17.4 16.4, 18.4
Marital status
Unmarried 1 1 Reference 0 0 Reference
Divorced/Widower 1.27 1.01 0.97, 1.05 11.6 −1.8 −3.0, -0.6
Married/cohabits 1.64 1.29 1.25, 1.33 27.3 14.5 13.5, 15.4
Income
Quintile 1 1 1 Reference 0 0 Reference
Quintile 3 1.39 1.32 1.09, 1.60 15.9 15.1 10.0, 20.1
Quintile 5 1.49 1.42 1.17, 1.73 20.4 20.4 15.6, 25.1
Municipality
Urban / rural 0.93 0.91 0.89, 0.93 6.1 −5.6 −6.4, -4.7
Social security #
Disability pension 0.97 0.92 0.88, 0.96 −19.2 −6.5 −7.8, -5.2
Social benefit 0.43 0.61 0.56, 0.67 −32.8 −17.9 −20.2,-15.5
*Participants that answered the nonparticipation questionnaire (QNP) were not included.
¤ Binomial regression, adjusted for all other variables except social security factors.
#Analysis restricted to subjects below 65 years of age and all variables entered in the adjusted model.
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http://www.biomedcentral.com/1471-2288/12/143prevalence data based on diagnosis by GPs. Contrary to
this, at least among people younger than 80 years, com-
mon problems like musculoskeletal pain, urine incontin-
ence and headache were reported more often in
participants compared to nonparticipants. The study
confirms associations between participation and marital
and socioeconomic status, and maintenance of increased
risk of death for nonparticipants even many years after
the surveys. Combining data from different sources pro-
vides the opportunity for future sensitivity analyses of
prevalence, incidence and association studies.
Except for the Tromsø Study [14], most national
[3,5,6,15] and international studies [1,16,17] have
reported corresponding reduction in participation rate
as the HUNT study. Reasons for the increase of nonpar-
ticipation in population based studies are thoroughly
discussed by Galea et al. [1], and may also be relevant to
the Norwegian population; People might be overloaded
with invitations to research and marketing surveys, there
is a general decrease in volunteerism parallel to decreasein participation in organizations and social activities,
there might be lack of immediate benefit for the individ-
ual participant and, generally, there is an increasing disil-
lusionment with science due to conflicting results
between different studies and changing recommenda-
tions for behavioral risk factors. Further, more complex
procedures regarding informed consent and study proto-
col as well as the burden of being invited to follow-up
studies, might decrease study participation [18,19].
The HUNT surveys have also become more complex
and demanding for participants with more comprehen-
sive questionnaires, interviews and examinations. Fur-
ther, in order to keep to laws and regulations for
medical research, an eight pages information folder was
sent together with the personal invitation and consent
form, even though invited persons prefer more simple
forms [18]. Increased number and size of follow-up
questionnaires (Q2 and Q3s), however, have not influ-
enced a stable response rate of these of about 75-80%
among those having attended the examination stations
Table 6 Overall and sex specific age adjusted mortality
(hazard ratio with 95% CI) according to participation in
the HUNT 1, HUNT 2 and the HUNT 3 study
Participation N Deaths Hazard ratio 95% CI
HUNT 1 (1984–86)
Women
Participated 38698 13450 1.00 Reference
Not participated 3571 1300 1.51 1.43-1.60
Men
Participated 36928 14206 1.00 Reference
Not participated 5018 1391 1.55 1.46-1.64
Overall
Participated 75626 27656 1.00 Reference
Not participated 8589 2691 1.50 1.44-1.57
HUNT 2 (1995–97)
Women
Participated 34469 5087 1.00 Reference
Not participated 9700 2833 1.82 1.74-1.91
Men
Participated 30237 5497 1.00 Reference
Not participated 12625 2261 1.64 1.56-1.73
Overall
Participated 64706 10584 1.00 Reference
Not participated 22325 5094 1.72 1.66-1.78
HUNT 3 (2006–08)
Women
Participated 27652 835 1.00 Reference
Not participated 19405 225 3.33 2.86-3.87
Men
Participated 22918 367 1.00 Reference
Not participated 23443 702 2.41 2.12-1.75
Overall
Participated 50571 619 1.00 Reference
Not participated 42848 1555 2.80 2.54-3.09
Adjusted for age by using age as the time scale.
The following subjects are excluded from the analyses: Persons < 20 years of
age at baseline study, and deaths between invitation and August 1986, August
1997, and August 2008 for HUNT1, HUNT2 and HUNT3, respectively. The
number of participants and nonparticipants therefore are lower than
previously for the entire study population.
Figure 2 Overall survival by participation in HUNT 1 in men
and women. Age used as timescale.
Figure 3 Overall survival by participation in HUINT 2 in men
and women. Age used as timescale.
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http://www.biomedcentral.com/1471-2288/12/143in three surveys. This indicates that the length and num-
ber of questionnaires have minor effect on the all over
participation in those who from the start had decided to
participate [20-22]. Our data show higher participation
rate in HUNT3 among persons previously having parti-
cipated in HUNT2 compared to nonparticipants, this is
in line with results from another Norwegian Cohort
Study [23]. Previous participation status in HUNT2 did,
however, not influence the participation rate for QNP,indicating similar attitude to contribute in data collec-
tion by short questionnaires in participants and
nonparticipants.
Low participation rates among persons under the age
of 40 probably reflects less opportunity to spend time,
limited short time benefit for a rather healthy age group
[1,24] and less altruistic attitude in contributing to re-
search [1]. Higher prevalence of chronic diseases having
regular follow-up by health care among nonparticipants
and opposite pattern for bothersome, but more trivial
symptoms in HUNT3, do support potential benefit for
the individual person to be of importance when consid-
ering participation. With increasing diagnostic and
therapeutic opportunities in the health care during the
last decades, present surveys are considered less as a
supplement to the health care.
Figure 4 Overall survival by participation in HUNT 3 in men
and women. Age used as timescale.
Figure 6 Risk of death by participation in HUNT 2 in men and
women adjusted for age (estimated at 50 years of age at
participation).
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http://www.biomedcentral.com/1471-2288/12/143The present study confirms previous studies having
reported low participation among people who are young,
unmarried, and belonging to lower socioeconomic groups
[5,6,21,25-28]. Interestingly, also in the HUNT Study per-
sons in higher socioeconomic groups, with presumably
highest time pressure, participated more often compared
with lower socioeconomic groups, indicating that motiv-
ation and attitude to research are important.
About 10% of nonparticipants claimed that they had
not received the invitation. We have no indication that
this can be explained by failure in the post delivery.
However, the invitations were sent in plastic foils, and
this could have been taken as advertising leaflets
and therefore not read. Economic costs should not
have much influence on the participation rate; the par-
ticipation was free of charge and most people wereFigure 5 Risk of death by participation in HUNT 1 in men and
women adjusted for age (estimated at 50 years of age at
participation).allowed by employers to meet during working time with
full salary. To avoid nonparticipation due to the incon-
venience of leaving work, the examination stations were
open even in the early evenings. Participation was not
stimulated by financial incentives, as previous studies
have not found this to increase response rates [20].
There has been a general positive attitude towards
health related research in the population of Nord-
Trøndelag. Since HUNT2 (1995-97) there have been
regular reports from HUNT-related research on the
HUNT web-site and in the media. The HUNT Study
has been supported by the Norwegian Parliament, the
Government, the Ministry of Health, and there has
been a close collaboration between the County Council,
the municipalities and HUNT Research Centre.Figure 7 Risk of death by participation in HUNT 3 in men and
women adjusted for age (estimated at 50 years of age at
participation).
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http://www.biomedcentral.com/1471-2288/12/143Additionally, the media have been strongly supportive of
the HUNT Study.
Influence on incidence and prevalence estimates
Most studies have found little evidence for substantial
bias due to nonparticipation [6,20,28-30]. In a Norwegian
community respiratory cohort study, increasing the re-
sponse rate from 65 to 89% after three reminders,
resulted in no overt differences in incidence rates of re-
spiratory symptoms and asthma as well as their associa-
tions to sex, age and smoking habits [31]. However, like
the present study, others have reported underestimation
of psychiatric disorders due to nonparticipation [5,32,33].
The scores of HADS anxiety and depression symptoms
cannot be directly compared with GP’s diagnosis of an-
xiety and depression. However, our finding of higher
prevalence of reported anxiety symptoms compared to
anxiety diagnosis, and lower prevalence of reported de-
pressive symptoms compared to depression diagnosis, in
participants compared to the background population,
indicates that depression is a more restricting factor for
participation than anxiety.
In line with other studies, nonparticipants in HUNT3
was also characterized by more unhealthy lifestyle
regarding tobacco smoking and physical inactivity
[26,34], and poorer somatic status [25,30,35,36]. Data
from the GPs further indicates as much as 50% higher
prevalence of angina, myocardial infarction and stroke
compared to the HUNT3 data, a pattern also found in
other cardiovascular studies [25,35]. Correspondingly,
the diabetes prevalence based on HUNT3 Q1 was
underestimated both compared to QNP and the GP data
based on diagnosis and prescription of medication.
Higher prevalence indicated by GP diagnosis than by
prescription data could be explained by prescription of
insulin by hospital doctors for young adults, and attain-
ment of adequate diabetic control by change in life style
for many patients with diabetes type II.
The difference in BMI estimated by self-reported mea-
sures compared to measures at the examination stations in
HUNT3 is in line with data from 2008 in an Australian
study [37]. Lower participation rate among lower socioeco-
nomic groups could contribute to reduce the difference be-
tween self-reported and measured anthropometrics.
Influence on associations
Many studies have found that subjects with risk behavior
like smoking, high alcohol consumption or drug use are
underrepresented in studies addressing these factors
[38,39]. The corresponding pattern in the present study
is mainly supposed to be related to differences in partici-
pation due to socioeconomic factors, as life style factors
by themselves amounted to a small fraction of all
questions. Studies on effects of environmental andoccupational exposures have experienced participation
bias depending on exposures measured [40,41]. By
analyzing exposures in blood samples and linking
HUNT data to external registers, a lot of associations
can be analyzed, but these should not be influenced by
participation as these topics have not been focused
prior to the surveys.
Nonparticipation bias may be greater in surveys with
higher participation rates compared with those with
lower participation rates [34], as the differences between
participants and nonparticipants may exaggerate real dif-
ferences between participants and the eligible population
sampled [25]. In the present study, however, inclusion of
nonparticipants answering QNP increased the preva-
lence estimates for chronic diseases slightly, but this cor-
rection decreased the gap slightly in prevalence between
the record data from general practice and HUNT parti-
cipants. If we assume that the prevalences found among
QNP participants 60 years and older, were representative
of the entire nonparticipant group, the combined preva-
lences for the nonparticipants and Q1 participants
would be close to the estimates found in the GP popula-
tion for myocardial infarction and asthma, whilst for
COPD, apoplexia and diabetes the GP population would
still have higher prevalences. Strategies for improving
participation rate should be developed and evaluated
prior to the next HUNT survey. In this population
increased participation rate seem to improve the exter-
nal validity of prevalence estimates. After HUNT3 there
has been a focus on overweight, obesity and laziness in
the media. This might introduce differential influence on
participation in future surveys due to stigmatization or
victim blaming.
Nonparticipation has been found to be associated with
two times higher risk of death independent of socioeco-
nomic category in nonparticipants compared to partici-
pants, both in a 20 years follow-up study of white collar
workers aged 35-55 years [42] and the FINRISK study,
inviting persons aged 35-74 years [43]. Higher mortality
risk among nonparticipants could be due to disabling
diseases hindering study participation. To avoid inclu-
sion of end stage patients in the present study, start of
follow-up after each of the HUNT surveys were set to 2
(or two) months after study inclusion.
Strengths of this study were inclusion of several data
sources for evaluation of nonparticipation bias, GP data
representing background data regarding diagnoses and
use of medication for the entire population, register data
revealing potential nonparticipation bias by socioeco-
nomic status and QNP reflecting the nonparticipation
group. The representativeness of responders to QNP for
the entire nonparticipation group might be questioned,
but sensitivity tests for chronic diseases indicate that the
validity of these data is rather good.
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from general practices to HUNT-data due to patient
confidentiality, use of registered diagnoses in general
practices that could lead to some extent of underestima-
tion of prevalence if doctors had not registered diagno-
ses given by previous GPs, and comparison of chronic
diagnoses with symptom report for the last 12 months
(for example head ache, urine incontinence). Back-
ground data from the GPs were collected three years
after HUNT, but this should not introduce important
bias in prevalence estimates.
Multiple testing may contribute to statistical signifi-
cances by chance, but having this in mind, there seem to
be consistent results on differences that researchers have
to take into consideration.
Conclusions
A participation rate of 54% in HUNT3 was lower than
expected, but for age groups 60-80 years the rates were
65% to 70%. Compared to nonparticipation question-
naire and records from general practice, the prevalences,
however, seem to be somewhat underestimated for
chronic diseases already being treated in the health care.
Higher prevalence among nonparticipants of cardiovas-
cular diseases, diabetes and mental distress seem to par-
allel differences in socioeconomic groups and risk factor
exposure. So far there is no reason to be concerned
about introduction of bias in association and causal
studies, but inclusion of a wide spectre of data and more
sources for background data provide opportunity for
addressing this in disease specific sensitivity studies.
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